Antimicrobial Working Group
AWG is a 501(c)(6) in support of public policy regarding antimicrobial drugs/diagnostics
Based in DC
🤖
AI Overview
With $110K in lobbying spend across 6 quarterly filings, Antimicrobial Working Group is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.
$110K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $40K |
| 2022 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
- •Federal funding for anitmicrobial resistance research and development; FY 22 Appropriations bills;
- •Federal funding for antimicrobial resistence research and development: FY 22 Appropriations bills;
- •Federal funding for antimicrobial resistance research and development: Final Omnibus Appropriations bill for FY 22; FY 23 federal budget and FY 23 appropriations.
- •Federal funding for antimicrobial resistance research and development: FY 23 federal budget and FY 23 appropriations.
Related Analysis
Related Investigations
Similar Clients
American Electric Power Company, INC. and Affiliated Corporations
$59.5M total spend
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
National Association of Children's Hospitals (N.a.c.h.)
$38.0M total spend
Distilled Spirits Council of the U.S., INC.
$34.7M total spend
Advanced Medical Technology Assn
$26.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.